Skip to main content
BNTX logo

BNTX · BioNTech SE

Track BNTX — free
$93.09 +0.97 (+1.05%) At close · Aug 14
Market Cap
$23.38B
Shares
251.20M

BioNTech SE Earnings Call Transcripts

Every quarterly earnings call for BioNTech SE (BNTX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q3
2026-11-03
2026 Q3 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-04
2026 Q2 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
2026 Q1 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
2025 Q4 and Full Year Earnings Call
Positive tone Oncology pipeline / Pumitamik (Bumitamik) Late-stage data readouts in 2026 BMS partnership & strategic deals
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
BioNTech SE Q3 FY2025 Earnings Call
Confident tone Pumitamig (PD-L1 VEGF-A bispecific) registrational progress mRNA cancer immunotherapy platform TPAM HER2 ADC program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
BioNTech SE Q1 FY2025 Earnings Call
Confident tone BNT327 Bispecific Antibody Pipeline Biotheus Acquisition HER2 ADC BNT323 BLA Submission
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
BioNTech SE Q4 FY2024 Earnings Call
Confident tone BNT327 pan-tumor oncology strategy Lung cancer clinical development Biotheus acquisition
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
BioNTech SE Q3 FY2024 Earnings Call
Confident tone BNT327 bispecific antibody (PD-L1/VEGF-A) mRNA cancer vaccine portfolio (FixVac and iNeST) COVID-19 vaccine franchise and strain adaptation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
BioNTech SE Q2 FY2024 Earnings Call
Confident tone Oncology pipeline execution and mRNA cancer vaccines IO plus ADC combination strategy Regulatory submissions and approvals
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
BioNTech SE Q1 FY2024 Earnings Call
Positive tone Oncology pipeline and pivotal trials mRNA cancer vaccine platform COVID-19 vaccine franchise
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
BioNTech SE Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
BioNTech SE Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
BioNTech SE Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
BioNTech SE Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
BioNTech SE Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
BioNTech SE Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
BioNTech SE Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
BioNTech SE Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
BioNTech SE Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
BioNTech SE Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
BioNTech SE Q1 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
BioNTech SE Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
BioNTech SE Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
BioNTech SE Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
BioNTech SE Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 269 filings 265 filers Visit website Investor relations